Literature DB >> 7804430

Overexpression of p53 protein and Ki67 proliferative index in hepatocellular carcinoma: an immunohistochemical study on 109 Italian patients.

A D'Errico1, W F Grigioni, M Fiorentino, P Baccarini, G L Grazi, A M Mancini.   

Abstract

The overexpression of p53 protein and the Ki67 proliferative index was evaluated in 96 hepatocellular carcinomas (HCC), 67 in cirrhotic livers and 29 in non-cirrhotic ones, and in 13 non-carcinomatous lesions, all surgically resected from Italian patients. Overexpression of p53 was detected only in carcinomatous lesions, and was significantly related to the grade of HCC (P < 0.001). In fact, p53 was observed in 7/7 (100%) cases of grade IV, 13/43 (30.3%) of grade III, and 10/46 (21.7%) of grade II. The relationship between p53 and Ki67 scores was determined in serial sections from corresponding areas of both diffuse and patchy immunoreactivity. In the overall population, p53-positive tumors showed a significantly higher Ki67 score (15.9 +/- 5.5% vs 9.2 +/- 4.3% [P < 0.001]). This observation was evident in all grades of HCC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7804430     DOI: 10.1111/j.1440-1827.1994.tb02947.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  9 in total

1.  Expression of proliferation associated antigens and detection of numerical chromosome aberrations in primary human liver tumours: relevance to tumour characteristics and prognosis.

Authors:  M Nolte; M Werner; A Nasarek; H Bektas; R von Wasielewski; J Klempnauer; A Georgii
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

2.  Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study.

Authors:  Hemda Schmilovitz-Weiss; Ana Tobar; Marisa Halpern; Izhar Levy; Esther Shabtai; Ziv Ben-Ari
Journal:  Diagn Pathol       Date:  2011-12-07       Impact factor: 2.644

3.  Is p53 gene mutation an indicatior of the biological behaviors of recurrence of hepatocellular carcinoma?

Authors:  I-Shyan Sheen; Kuo-Shyang Jeng; Ju-Yann Wu
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

4.  Apoptosis and cellular proliferation in oesophageal squamous cell carcinomas: differences between keratinizing and nonkeratinizing types.

Authors:  M Ohbu; M Saegusa; I Okayasu
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.

Authors:  R Saffroy; J C Lelong; D Azoulay; M Salvucci; M Reynes; H Bismuth; B Debuire; A Lemoine
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

6.  Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinoma.

Authors:  Stefan Welte; Toni Urbanik; Christin Elßner; Nicole Kautz; Bruno Christian Koehler; Nina Waldburger; Justo Lorenzo Bermejo; Federico Pinna; Karl-Heinz Weiss; Peter Schemmer; Dirk Jaeger; Thomas Longerich; Kai Breuhahn; Henning Schulze-Bergkamen
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

7.  Potential therapeutic role of Tridham in human hepatocellular carcinoma cell line through induction of p53 independent apoptosis.

Authors:  Ravindran Jaganathan; Vijaya Ravinayagam; Sachdanandam Panchanadham; Shanthi Palanivelu
Journal:  BMC Complement Altern Med       Date:  2013-11-21       Impact factor: 3.659

8.  Liver cancers with stem/progenitor-cell features - a rare chemotherapy-sensitive malignancy.

Authors:  Bruno Christian Köhler; Nina Waldburger; Kai Schlamp; Dirk Jäger; Karl Heinz Weiss; Henning Schulze-Bergkamen; Peter Schirmacher; Christoph Springfeld
Journal:  Oncotarget       Date:  2017-06-05

9.  High cytoplasmic expression of Krüppel-like factor 4 is an independent prognostic factor of better survival in hepatocellular carcinoma.

Authors:  Hui-Ting Hsu; Pei-Ru Wu; Chih-Jung Chen; Li-Sung Hsu; Chung-Min Yeh; Ming-Tai Hsing; Yi-Shan Chiang; Ming-Tsung Lai; Kun-Tu Yeh
Journal:  Int J Mol Sci       Date:  2014-06-03       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.